Nigeria vs SEAR: Hepatitis B surface antigen (HBsAg) prevalence
Nigeria
2.7%
in 2024
SEAR
0.2%
in 2024
Nigeria rank
8th
SEAR rank
5th
Hepatitis B surface antigen (HBsAg) prevalence over time
- Nigeria
- SEAR
How they compare
Nigeria currently reports 2.7% against 0.2% in SEAR, a difference of 2.5%.
That makes Nigeria's figure about 13.5 times SEAR's.
Across all 10 years both countries report, Nigeria has been ahead every year.
Nigeria ranks 8th and SEAR ranks 5th of 194 countries.
Nigeria has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Nigeria | SEAR | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 3.7% | 0.4% | 3.3% | Nigeria |
| 2020s | 3.1% | 0.3% | 2.9% | Nigeria |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hepatitis b surface antigen (hbsag) prevalence, Nigeria or SEAR?
- Nigeria, at 2.7% against 0.2% in SEAR as of 2024.
- What is the difference in hepatitis b surface antigen (hbsag) prevalence between Nigeria and SEAR?
- 2.5%, with Nigeria ahead.
- How many years of comparable data are there for Nigeria and SEAR?
- 10 years are reported by both, from 2015 to 2024.
- How do Nigeria and SEAR rank globally for hepatitis b surface antigen (hbsag) prevalence?
- Nigeria ranks 8th and SEAR ranks 5th of 194 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Hepatitis B surface antigen (HBsAg) prevalence (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.